Lyxumia contains Lixisenatide 10mcg, a GLP-1 receptor agonist that works on several mechanisms involved in blood sugar regulation. It enhances glucose-dependent insulin secretion, reduces glucagon release when blood glucose is elevated, and slows gastric emptying.

This combination can help reduce post-meal glucose rises and improve overall glycemic control. Lyxumia is generally incorporated into an individualized diabetes management program that may include dietary measures and other antidiabetic medicines.

Brand: Lyxumia

Active Ingredient: Lixisenatide 10mcg

Form: Injection

Pack: 1 injection

Category: GLP-1 receptor agonist

Administration: Subcutaneous

Use according to the prescribed dosing schedule and medical guidance.